SS&H Financial Advisors Inc. acquires 818 shares of Zoetis Inc. (NYSE:ZTS)

SS&H Financial Advisors Inc. increased its holdings in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 15.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,118 shares of the company’s stock after acquiring an additional 818 shares during the period. Holdings of SS&H Financial Advisors Inc. holdings in Zoetis were worth $1,061,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have recently made changes to their positions in the business. Webster Bank NA boosted its holdings in Zoetis by 89.1% in the first quarter. Webster Bank NA now owns 174 shares of the company’s stock worth $29,000 after purchasing an additional 82 shares in the last quarter. Quarry LP boosted its holdings in Zoetis by 273.2% in the second quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after acquiring an additional 153 shares in the last quarter. Neo Ivy Capital Management acquired a new position in Zoetis in the fourth quarter valued at approximately $40,000. LRI Investments LLC purchased a new position in Zoetis in the 1st quarter worth approximately $43,000. Finally, Hazlett Burt & Watson Inc. boosted its holdings in Zoetis by 60.7% in the first quarter. Hazlett Burt & Watson Inc. now owns 270 shares of the company’s stock worth $46,000 after buying an additional 102 shares in the last quarter. 92.80% of shares are owned by institutional investors.

Analysts set new price targets

Several research analysts recently weighed in on the stock. BTIG Research upped their target price on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Argus upgraded shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler upped their target price on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Finally, Stifel Nicolaus boosted their target price on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Nine research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $220.38, according to MarketBeat.com.

Get the latest research report on Zoetis

Zoetis stock fell 0.5%

ZTS opened at $194.49 on Wednesday. The company has a quick ratio of 2.09, a current ratio of 3.45, and a debt-to-equity ratio of 1.32. The stock has a market cap of $88.74 billion, a price-to-earnings ratio of 37.47, a PEG ratio of 2.99 and a beta of 0.88. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The company’s 50-day moving average price is $186.64, and its two-hundred-day moving average price is $175.09.

Zoetis (NYSE:ZTS – Get Free Report ) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. The company had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. Zoetis’s revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company posted EPS of $1.41. As a group, equities analysts expect Zoetis Inc. to post 5.84 earnings per share for the current year.

About Zoetis

(Free Report)

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines, vaccines and diagnostic products and services in the United States and internationally. The company mainly markets products by species, including livestock such as cattle, swine, poultry, fish and sheep and others; and pets including dogs, cats and horses.

Featured stories

Want to see what other hedge funds own ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Zoetis Inc. (NYSE:ZTS – Free Report).

Get news and reviews for Zoetis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Zoetis and related companies with MarketBeat.com’s FREE daily email newsletter.